Interval cancers in a FOBT-based colorectal cancer population screening programme: Implications for stage, gender and tumour site

Gut

Volumn 61, Issue 4, 2012, Pages 576-581

  Steele, R J C ^a,b   McClements, P ^c   Watling, C ^c   Libby, G ^b   Weller, D ^d   Brewster, D H ^c   Black, R ^c   Carey, F A ^a   Fraser, C G ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b King's Cross Hospital   (United Kingdom)

^c INFORMATION SERVICES DIVISION   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SCREENING; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CLINICAL EVALUATION; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; OVERALL SURVIVAL; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; SEX DIFFERENCE;

AGE FACTORS; AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OCCULT BLOOD; PILOT PROJECTS; PROGNOSIS; REAGENT KITS, DIAGNOSTIC; SCOTLAND; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 84857798015     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300535     Document Type: Article

References (24)

1. Raffle A, Gray M. Screening: Evidence and Practice. Oxford: University Press, 2007.
2. Steele RJ, McClements PL, Libby G, et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009;58:530-5.
3. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 1993;328:1365-71. (Pubitemid 23131388)
4. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996;348:1472-7. (Pubitemid 26400242)
5. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996;348:1467-71. (Pubitemid 26400241)
6. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008;95:1029-36.
7. Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004;126:1674-80. (Pubitemid 38736331)
8. Steele RJC, Parker R, Patnick J, et al. A demonstration pilot for colorectal cancer screening in the United Kingdom: a new concept in the introduction of health care strategies. J Med Screen 2001;8:197-202.
9. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004;329:133-5.
10. Brewster D, Crichton J, Harvey JC, et al. Completeness of case ascertainment in a Scottish Regional Cancer Registry for the year 1992. Public Health 1997;111:339-43. (Pubitemid 27412226)
11. Brewster DH, Stockton DL. Ascertainment of breast cancer by the Scottish Cancer Registry: an assessment based on comparison with five independent breast cancer trials databases. Breast 2008;17:106-8.
12. Steele RJC, Kostourou I, McClements P, et al. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening. BMJ 2010;341:c5531.
13. Paimela H, Malila N, Palva T, et al. Early detection of colorectal cancer with faceal occult blood test screening. Br J Surg 2010;97:1567-71.
14. Steele RJ, Kostouruo I, McClements P, et al. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen 2010;17:68-74.
15. Weller D, Coleman D, Robertson R, et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007;97:1601-5. (Pubitemid 350249359)
16. Brenner H, Hoffmeister M, Arndt V, et al. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 2007;96:828-31. (Pubitemid 46376632)
17. Regula J, Rupinski M, Kraszewka E, et al. Colonoscopy in colorectal cancer screening for detection of advanced neoplasia. N Eng J Med 2006;355:1863-72. (Pubitemid 44664644)
18. Brenner H, Haug U, Hundt S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol 2010;105:2457-64.
19. Malila N, Oivanen T, Malminiemi O, et al. Test, episode and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 2008;337:a2261.
20. Myers AM, Saunders CR, Chalmers DG. The haemoglobin level of elderly people. Lancet 1968;2:261-3.
21. Sadik R, Abrahamsson H, Stolzer PO. Gender differences in gut transit shown with a newly developed radiological procedure. Scan J Gastroenterol 2003;38:36-42. (Pubitemid 36152862)
22. Scottish Health Survey. http://www.scotland.gov.uk/Topics/Statistics/ Browse/Health/scottish-health-survery.
23. Van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90. (Pubitemid 351899018)
24. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet;2010;375:1624-33.